Professor of Public Law
Editor Biobank Perspectives
Anna-Sara Lind joined CRB in September 2011 to work with the legal aspects of research conducted on human tissue samples within BBMRI.se and BBMRI-LPC. Anna-Sara Lind is Professor of Public Law at the Department of Law at Uppsala University and is tied part-time to CRB. Her research focuses on public law, EU law and fundamental rights and on how EU law and international law interacts in the fields of Medical law and welfare state law in a complex constitutional reality.
She is editor of our newsletter Biobank Perspectives: Current issues in ethics and law.
Phone: +46 18 471 61 99
Recently in the media
- Öppenheten förstör chansen till patent
Svenska Dagbladet, debatt, 2015-06-21
Stem cell treatment of type 1 diabetes
We provide ethical and legal analysis and guidance on development of products for treating type 1 diabetes, using cells derived from human embryonic stem cells.
ELSI-Service for BBMRI.se
We have run ELSI-Services for BBMRI.se (BioBanking and Molecular Resource Infrastructure of Sweden): a national effort for efficient and automated collection of biological material funded by the Swedish Research Council. Now replaced by Biobank Sweden.
Biobank and registry ethics & law
For many years, researchers at CRB have provided constructive advise on how to deal with ethical and legal aspects of research using human tissue material and personal data. We have collaborated with biomedical scientists and published our findings in peer reviewed journals. As a summary of this research we have compiled a list of publications with abstracts. We have grouped them thematically to help you find the ones you might be interested in reading. Our publications deal with ethical frameworks and policy, regulatory aspects of biobank and registry research, informed consent, ethical review, integrity concerns, trust, genetic testing, indicental findings, commercialization, public and patient perceptions, rare diseases, children & biobanks & genetics, and biobank studies.